BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20413880)

  • 1. VEGF haplotypes are associated with increased risk to progressive supranuclear palsy and corticobasal syndrome.
    Borroni B; Del Bo R; Goldwurm S; Archetti S; Bonvicini C; Agosti C; Bigni B; Papetti A; Ghezzi S; Sacilotto G; Pezzoli G; Gennarelli M; Bresolin N; Comi GP; Padovani A
    J Alzheimers Dis; 2010; 21(1):87-94. PubMed ID: 20413880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia.
    Yokoyama JS; Karch CM; Fan CC; Bonham LW; Kouri N; Ross OA; Rademakers R; Kim J; Wang Y; Höglinger GU; Müller U; Ferrari R; Hardy J; ; Momeni P; Sugrue LP; Hess CP; James Barkovich A; Boxer AL; Seeley WW; Rabinovici GD; Rosen HJ; Miller BL; Schmansky NJ; Fischl B; Hyman BT; Dickson DW; Schellenberg GD; Andreassen OA; Dale AM; Desikan RS
    Acta Neuropathol; 2017 May; 133(5):825-837. PubMed ID: 28271184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
    Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
    JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary evidence that VEGF genetic variability confers susceptibility to frontotemporal lobar degeneration.
    Borroni B; Ghezzi S; Agosti C; Archetti S; Fenoglio C; Galimberti D; Scarpini E; Di Luca M; Bresolin N; Comi GP; Padovani A; Del Bo R
    Rejuvenation Res; 2008 Aug; 11(4):773-80. PubMed ID: 18729809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microtubule-associated protein tau genetic variations are uncommon cause of frontotemporal dementia in south India.
    Aswathy PM; Jairani PS; Verghese J; Gopala S; Mathuranath PS
    Neurobiol Aging; 2014 Feb; 35(2):443.e23-4. PubMed ID: 24041972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the tau gene region chromosome inversion in progressive supranuclear palsy, corticobasal degeneration, and related disorders.
    Webb A; Miller B; Bonasera S; Boxer A; Karydas A; Wilhelmsen KC
    Arch Neurol; 2008 Nov; 65(11):1473-8. PubMed ID: 19001166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration.
    Pittman AM; Myers AJ; Abou-Sleiman P; Fung HC; Kaleem M; Marlowe L; Duckworth J; Leung D; Williams D; Kilford L; Thomas N; Morris CM; Dickson D; Wood NW; Hardy J; Lees AJ; de Silva R
    J Med Genet; 2005 Nov; 42(11):837-46. PubMed ID: 15792962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy.
    Ezquerra M; Pastor P; Gaig C; Vidal-Taboada JM; Cruchaga C; Muñoz E; Martí MJ; Valldeoriola F; Aguilar M; Calopa M; Hernandez-Vara J; Tolosa E
    Neurobiol Aging; 2011 Mar; 32(3):547.e11-6. PubMed ID: 19879020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy.
    Chen JA; Wang Q; Davis-Turak J; Li Y; Karydas AM; Hsu SC; Sears RL; Chatzopoulou D; Huang AY; Wojta KJ; Klein E; Lee J; Beekly DL; Boxer A; Faber KM; Haase CM; Miller J; Poon WW; Rosen A; Rosen H; Sapozhnikova A; Shapira J; Varpetian A; Foroud TM; Levenson RW; Levey AI; Kukull WA; Mendez MF; Ringman J; Chui H; Cotman C; DeCarli C; Miller BL; Geschwind DH; Coppola G
    JAMA Neurol; 2015 Apr; 72(4):414-22. PubMed ID: 25706306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival in progressive supranuclear palsy and frontotemporal dementia.
    Chiu WZ; Kaat LD; Seelaar H; Rosso SM; Boon AJ; Kamphorst W; van Swieten JC
    J Neurol Neurosurg Psychiatry; 2010 Apr; 81(4):441-5. PubMed ID: 20360166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease.
    Borroni B; Agosti C; Magnani E; Di Luca M; Padovani A
    Curr Med Chem; 2011; 18(17):2655-60. PubMed ID: 21568901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial aggregation in Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Borroni B; Goldwurm S; Cerini C; Cosseddu M; Meucci N; Mariani C; Pezzoli G; Padovani A
    Eur J Neurol; 2011 Jan; 18(1):195-7. PubMed ID: 20482608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel haplotypes in 17q21 are associated with progressive supranuclear palsy.
    Pastor P; Ezquerra M; Perez JC; Chakraverty S; Norton J; Racette BA; McKeel D; Perlmutter JS; Tolosa E; Goate AM
    Ann Neurol; 2004 Aug; 56(2):249-58. PubMed ID: 15293277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure of the tau haplotype in controls and in progressive supranuclear palsy.
    Pittman AM; Myers AJ; Duckworth J; Bryden L; Hanson M; Abou-Sleiman P; Wood NW; Hardy J; Lees A; de Silva R
    Hum Mol Genet; 2004 Jun; 13(12):1267-74. PubMed ID: 15115761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.
    Pastor P; Moreno F; Clarimón J; Ruiz A; Combarros O; Calero M; López de Munain A; Bullido MJ; de Pancorbo MM; Carro E; Antonell A; Coto E; Ortega-Cubero S; Hernandez I; Tárraga L; Boada M; Lleó A; Dols-Icardo O; Kulisevsky J; Vázquez-Higuera JL; Infante J; Rábano A; Fernández-Blázquez MÁ; Valentí M; Indakoetxea B; Barandiarán M; Gorostidi A; Frank-García A; Sastre I; Lorenzo E; Pastor MA; Elcoroaristizabal X; Lennarz M; Maier W; Rámirez A; Serrano-Ríos M; Lee SE; Sánchez-Juan P;
    J Alzheimers Dis; 2016; 49(2):343-52. PubMed ID: 26444794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong association of a novel Tau promoter haplotype in progressive supranuclear palsy.
    de Silva R; Weiler M; Morris HR; Martin ER; Wood NW; Lees AJ
    Neurosci Lett; 2001 Oct; 311(3):145-8. PubMed ID: 11578815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative tauopathy.
    Li Y; Chen JA; Sears RL; Gao F; Klein ED; Karydas A; Geschwind MD; Rosen HJ; Boxer AL; Guo W; Pellegrini M; Horvath S; Miller BL; Geschwind DH; Coppola G
    PLoS Genet; 2014 Mar; 10(3):e1004211. PubMed ID: 24603599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy.
    Di Maria E; Tabaton M; Vigo T; Abbruzzese G; Bellone E; Donati C; Frasson E; Marchese R; Montagna P; Munoz DG; Pramstaller PP; Zanusso G; Ajmar F; Mandich P
    Ann Neurol; 2000 Mar; 47(3):374-7. PubMed ID: 10716259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology.
    Heckman MG; Brennan RR; Labbé C; Soto AI; Koga S; DeTure MA; Murray ME; Petersen RC; Boeve BF; van Gerpen JA; Uitti RJ; Wszolek ZK; Rademakers R; Dickson DW; Ross OA
    JAMA Neurol; 2019 Jun; 76(6):710-717. PubMed ID: 30882841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases.
    Coppola G; Chinnathambi S; Lee JJ; Dombroski BA; Baker MC; Soto-Ortolaza AI; Lee SE; Klein E; Huang AY; Sears R; Lane JR; Karydas AM; Kenet RO; Biernat J; Wang LS; Cotman CW; Decarli CS; Levey AI; Ringman JM; Mendez MF; Chui HC; Le Ber I; Brice A; Lupton MK; Preza E; Lovestone S; Powell J; Graff-Radford N; Petersen RC; Boeve BF; Lippa CF; Bigio EH; Mackenzie I; Finger E; Kertesz A; Caselli RJ; Gearing M; Juncos JL; Ghetti B; Spina S; Bordelon YM; Tourtellotte WW; Frosch MP; Vonsattel JP; Zarow C; Beach TG; Albin RL; Lieberman AP; Lee VM; Trojanowski JQ; Van Deerlin VM; Bird TD; Galasko DR; Masliah E; White CL; Troncoso JC; Hannequin D; Boxer AL; Geschwind MD; Kumar S; Mandelkow EM; Wszolek ZK; Uitti RJ; Dickson DW; Haines JL; Mayeux R; Pericak-Vance MA; Farrer LA; ; Ross OA; Rademakers R; Schellenberg GD; Miller BL; Mandelkow E; Geschwind DH
    Hum Mol Genet; 2012 Aug; 21(15):3500-12. PubMed ID: 22556362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.